Cost-effectiveness of Integrated Collaborative Care for Comorbid Major Depression in Patients with Cancer

Overview

Journal J Psychosom Res

Specialty Psychiatry

Date 2015 Dec 15

PMID 26652589

Citations 19

Authors

A Duarte

J Walker

S Walker

G Richardson

C Holm Hansen

P MARTIN

G Murray

M Sculpher

M Sharpe

Affiliations

Soon will be listed here.

Abstract

Objectives: Comorbid major depression is associated with reduced quality of life and greater use of healthcare resources. A recent randomised trial (SMaRT, Symptom Management Research Trials, Oncology-2) found that a collaborative care treatment programme (Depression Care for People with Cancer, DCPC) was highly effective in treating depression in patients with cancer. This study aims to estimate the cost-effectiveness of DCPC compared with usual care from a health service perspective.

Methods: Costs were estimated using UK national unit cost estimates and health outcomes measured using quality-adjusted life-years (QALYs). Incremental cost-effectiveness of DCPC compared with usual care was calculated and scenario analyses performed to test alternative assumptions on costs and missing data. Uncertainty was characterised using cost-effectiveness acceptability curves. The probability of DCPC being cost-effective was determined using the UK National Institute for Health and Care Excellence's (NICE) cost-effectiveness threshold range of £ 20,000 to £ 30,000 per QALY gained.

Results: DCPC cost on average £ 631 more than usual care per patient, and resulted in a mean gain of 0.066 QALYs, yielding an incremental cost-effectiveness ratio of £ 9549 per QALY. The probability of DCPC being cost-effective was 0.9 or greater at cost-effectiveness thresholds above £ 20,000 per QALY for the base case and scenario analyses.

Conclusions: Compared with usual care, DCPC is likely to be cost-effective at the current thresholds used by NICE. This study adds to the weight of evidence that collaborative care treatment models are cost-effective for depression, and provides new evidence regarding their use in specialist medical settings.

Citing Articles

Economic Evaluations of Health Service Interventions Targeting Patients with Multimorbidities: A Scoping Literature Review.

Ferrara L, Ardito V, Tozzi V, Tarricone R Int J Integr Care. 2025; 25(1):3.

PMID: 39866291 PMC: 11760752. DOI: 10.5334/ijic.8623.

Can integrated care interventions strengthen primary care and improve outcomes for patients with chronic diseases? A systematic review and meta-analysis.

Zhang Y, Stokes J, Anselmi L, Bower P, Xu J Health Res Policy Syst. 2025; 23(1):5.

PMID: 39762867 PMC: 11702112. DOI: 10.1186/s12961-024-01260-1.

Collaborative care approaches for people with severe mental illness.

Reilly S, Hobson-Merrett C, Gibbons B, Jones B, Richards D, Plappert H Cochrane Database Syst Rev. 2024; 5:CD009531.

PMID: 38712709 PMC: 11075124. DOI: 10.1002/14651858.CD009531.pub3.

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial.

Steel J, George C, Terhorst L, Yabes J, Reyes V, Zandberg D Lancet. 2024; 403(10434):1351-1361.

PMID: 38490230 PMC: 11556417. DOI: 10.1016/S0140-6736(24)00015-1.

Care Delivery Interventions for Individuals with Cancer: A Literature Review and Focus on Gastrointestinal Malignancies.

Lam A, Moore V, Nipp R Healthcare (Basel). 2024; 12(1).

PMID: 38200936 PMC: 10779432. DOI: 10.3390/healthcare12010030.

References

Sharpe M, Walker J, Holm Hansen C, Martin P, Symeonides S, Gourley C . Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial. Lancet. 2014; 384(9948):1099-108. DOI: 10.1016/S0140-6736(14)61231-9. View

Matthews J, Altman D, Campbell M, Royston P . Analysis of serial measurements in medical research. BMJ. 1990; 300(6719):230-5. PMC: 1662068. DOI: 10.1136/bmj.300.6719.230. View

Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G . Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004; 42(12):1211-21. DOI: 10.1097/00005650-200412000-00008. View

Walker J, Holm Hansen C, Martin P, Symeonides S, Ramessur R, Murray G . Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2015; 1(5):343-50. DOI: 10.1016/S2215-0366(14)70313-X. View

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

Ferrari A, Charlson F, Norman R, Patten S, Freedman G, Murray C . Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013; 10(11):e1001547. PMC: 3818162. DOI: 10.1371/journal.pmed.1001547. View

Ekers D, Murphy R, Archer J, Ebenezer C, Kemp D, Gilbody S . Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord. 2013; 149(1-3):14-22. DOI: 10.1016/j.jad.2013.02.032. View

Simon G, VonKorff M, BARLOW W . Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995; 52(10):850-6. DOI: 10.1001/archpsyc.1995.03950220060012. View

Walker S, Walker J, Richardson G, Palmer S, Wu Q, Gilbody S . Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer. Psychol Med. 2013; 44(7):1451-60. DOI: 10.1017/S0033291713002079. View

10.

Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B . Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370(9590):851-8. DOI: 10.1016/S0140-6736(07)61415-9. View

11.

Katon W . Collaborative depression care models: from development to dissemination. Am J Prev Med. 2012; 42(5):550-2. DOI: 10.1016/j.amepre.2012.01.017. View

12.

van Steenbergen-Weijenburg K, van der Feltz-Cornelis C, Horn E, van Marwijk H, Beekman A, Rutten F . Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review. BMC Health Serv Res. 2010; 10:19. PMC: 2826303. DOI: 10.1186/1472-6963-10-19. View

13.

Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J . Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet. 2008; 372(9632):40-8. DOI: 10.1016/S0140-6736(08)60991-5. View

14.

Walker J, Sharpe M . Depression Care for People with Cancer: a collaborative care intervention. Gen Hosp Psychiatry. 2009; 31(5):436-41. DOI: 10.1016/j.genhosppsych.2009.05.010. View

15.

Gilbody S, Bower P, Whitty P . Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry. 2006; 189:297-308. DOI: 10.1192/bjp.bp.105.016006. View

16.

Jacob V, Chattopadhyay S, Sipe T, Thota A, Byard G, Chapman D . Economics of collaborative care for management of depressive disorders: a community guide systematic review. Am J Prev Med. 2012; 42(5):539-49. DOI: 10.1016/j.amepre.2012.01.011. View

17.

Manca A, Hawkins N, Sculpher M . Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2004; 14(5):487-96. DOI: 10.1002/hec.944. View

18.

Young A, Klap R, Sherbourne C, Wells K . The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001; 58(1):55-61. DOI: 10.1001/archpsyc.58.1.55. View

19.

Grochtdreis T, Brettschneider C, Wegener A, Watzke B, Riedel-Heller S, Harter M . Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. PLoS One. 2015; 10(5):e0123078. PMC: 4437997. DOI: 10.1371/journal.pone.0123078. View

20.

Egede L . Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007; 29(5):409-16. DOI: 10.1016/j.genhosppsych.2007.06.002. View